ReviewFrontiers in aging neuroscience2026
Transcranial direct current stimulation to improve cognitive function in patients with vascular cognitive impairment: a literature review.
Review in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Vascular pathology represents the second most common cause of cognitive impairment after Alzheimer's disease and contributes substantially to mixed dementia involving both vascular and neurodegenerative mechanisms. Vascular cognitive impairment (VCI) emerges as a term encompassing cognitive impairments resulting from stroke, cerebral small vessel disease (CSVD), or other forms of vascular pathology. While numerous studies have demonstrated the beneficial effects of transcranial direct current stimulation (tDCS) on mild cognitive impairment and dementia, evidence specifically addressing its efficacy in VCI remains limited. We conducted a structured narrative review to summarize the effects of tDCS on cognitive rehabilitation in individuals with VCI. Studies were included if participants had cognitive impairment related to vascular pathology and if cognitive severity ranged from mild cognitive impairment to dementia. Eighteen studies met the inclusion criteria. Among the included studies, 15 were conducted in post-stroke cognitive impairment (PSCI) populations, whereas only three studies focused on non-stroke VCI. Across the included studies, tDCS has demonstrated promising effects on global cognition and executive function in PSCI populations. Combining tDCS with cognitive or motor rehabilitation appeared to further facilitate cognitive recovery in PSCI populations. Neuroimaging and EEG findings suggest that tDCS may be associated with cognitive improvement through potential modulation of cortical excitability, neural oscillatory activity, and functional connectivity. In addition, preliminary evidence suggests tDCS may have the potential to modulate cerebral blood flow, indicating a potential modulatory effect on neurovascular coupling. However, most available studies were conducted in patients with PSCI, with insufficient evidence in non-stroke VCI populations related to CSVD. Furthermore, the neurophysiological mechanisms by which tDCS modulates vascular and cognitive function remain poorly understood, warranting further investigation in future studies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.